Objectives: The purpose of the current study is to describe the prevalence and characteristics of antimicrobial stewardship programs (ASP) in Gulf Cooperation Council (GCC) states to explore opportunities and overcome barriers to effective ASP implementation.
Introduction
The increasing emergence of antimicrobial resistance (AR) presents a serious public health crisis and adversely affects patient clinical outcomes resulting in higher rates of morbidity and mortality as well as adding considerable and avoidable costs to the already overburdened healthcare systems (Nathan and Cars, 2014) . Recently, organisations such as the Centers for Disease Control and the World Health Organization have declared AR a public health crisis and a threat to national security (Centers for Disease Control, 2013; World Health Organization, 2013) .
A national surveillance of antimicrobial resistance among Gram-positive bacteria in Saudi Arabia revealed high resistance among coagulase-negative staphylococci (oxacillin: 63%), Staphylococcus aureus (methicillinresistant S. aureus: 32%) and pneumococci (penicillin G: 33%; erythromycin: 26%; ceftriaxone: 11%) (Shibl et al., 2014) . Moreover, Gulf Cooperation Council (GCC) states share a high prevalence of extended-spectrum-B-lactamase (ESBL) and carbapenemase-producing gram negative bacilli, most of which are associated with nosocomial infections (Zowawi et al., 2013) .
Antibiotic misuse is a major determining factor of AR, occurring in around 50% of prescribing (Paterson, 2006) . GCC countries are facing challenges of emerging antimicrobial resistance with no clear, regional guidelines for antimicrobial use or precise policies for restricting and monitoring antimicrobial prescriptions (Aly and Balkhy, 2012) .
The antimicrobial stewardship program (ASP) is a strategic initiative to optimise the use of existing antibioticsfor those who need them -thus preserving their effectiveness and delaying emergence of resistance. As a patient-centred multifaceted program, ASP ensures that patients receive the right antibiotic choice, the right dose and the shortest effective duration to improve their outcome and minimise unintended consequences.
The proven benefits of ASPs have led to increasing calls for their implementation in all hospitals (File et al., 2014) . Despite its publicity in most North American, European and Australian hospitals, there are limited assessments of ASP strategies across hospitals in the Arabian Gulf. Our survey aimed to evaluate the current status of ASP in the GCC, its core components, funding, barriers and outcomes. Insights from this regional survey may aid in understanding the challenges to and opportunities for developing effective ASP in the region that will help develop regional guidelines for antibiotic consumption and resistance surveillance. It was disseminated to healthcare institutions in GCC countries during the period January to March 2013. The study received approval from The Institutional Review Board of King Fahad Medical City. Informed consent was formulated highlighting the voluntary participation, confidentiality and use of the survey data for research purposes only. The survey tool was posted on a website for healthcare professionals (http://www.doctorksa.com) targeting 2000 healthcare professionals. In addition, 20 personalised emails were sent to infectious diseases and pharmacy networks representing different healthcare systems.
Methods
The target population was infectious diseases specialists, pharmacists, microbiologists or other physicians / administrators with an interest or experience in antibiotic policies. Instructions specified that a single survey be filled out by one person at each hospital. The survey tool contained 21 questions (Appendix); it collected information on hospital demographic characteristics, hospital size, self-identified hospital classification and teaching status. Presence of electronic prescribing systems was assessed. Participants' demographic data in terms of job title, and role in hospital antimicrobial and drug and therapeutic committees were collected. Data on the presence or absence of an ASP, ASP strategies used, outcome measures and barriers identified were collected. Data were managed and analysed using the SPSS statistical analysis package version 20. Categorical variables were presented as frequencies and percentages.
Results
Forty-seven participants from four GCC states, namely Saudi Arabia, Oman, United Arab Emirates and Bahrain, submitted completed surveys. Participants from Saudi Arabia constituted the bulk 38/47(80.9%), while only two participants were from Oman, United Arab Emirates and Bahrain each. Unfortunately there was no participation from Kuwait or Qatar (the total number of hospitals in Saudi Arabia is 415). Demographic characteristics of participants are illustrated in Table 1 .
Most of the participating institutions were tertiary care teaching hospitals with a capacity in the range of 200-800 beds as illustrated in Table 2 .
Twenty-nine out of 47 participating hospitals (61.7%) had ASP in place. Of these, the top three objectives for the hospital current or planned ASP were to reduce resistance, improve clinical outcome and reduce costs (72%, 70% and 45%, respectively). Multiple barriers were identified to effective stewardship programs including limited personnel and lack of funding, as illustrated in Table 3 . Almost 75% of established stewardship programs had no dedicated funding, constituting a major barrier. Antimicrobial stewardship rounds occurred in 51% of institutions, most frequently in their intensive care unit.
Among all participating institutions, 37 (78.7%) had antimicrobial guidelines that included first choice antibiotics, therapy of specific infectious diseases, dosage of specific antibiotics including calculation in special populations (renal or liver impairment), surgical prophylaxis and duration of prescription as illustrated in Table 4 .
Preauthorisation of restricted antimicrobial therapy existed in 40 (85%) hospitals with 27.7% requiring preauthorisation before the first dose, 25.5% before the second dose and 15% during the working day. Other methods of restriction were used by 27.7% of the hospitals. Out of 47 institutions, 30 (63.8%) had antimicrobial auditing, while 29 (61.7%) had reporting and monitoring antibiotics. Electronic prescription was found in 34 (72%) participating hospitals.
Among the reported significant impacts of existing ASP were reduction of broad spectrum antibiotic use, hospitalacquired infection, inappropriate prescribing and antimicrobial resistance. Reduced length of stay or mortality metrics and reduction in direct antibiotic cost were other benefits as illustrated in Table 5 .
Discussion
To our knowledge, this is the first published assessment of ASPs in GCC states. The survey results indicate that many ASPs are active in the region; however, the definition of an ASP was unclear in the survey and may have been interpreted differently by various respondents. • Administration not aware of ASP 4 (8.5)
• Lack of personnel or funding 10 (21.3)
• Multiple factors 23 (48.9)
• Obstruction from prescribers 5 (10.6)
• Others 5 (10.6) Preauthorisation and restricted list of antimicrobial agents appears to be the core stewardship strategy practised in GCC countries; this is consistent with the IDSA Emerging Infections Network survey (Johansson et al., 2011) . Postprescription review with feedback has been associated with decreased and improved antimicrobial use (Arnold et al., 2006; Cosgrove et al., 2007; Di Pentima and Chan, 2010) .
The latter strategy was not evaluated in the current study although the presence of stewardship rounds in half of the institutions may indirectly reflect post-prescription review of antibiotics.
A noticeable finding of our study is the reported favourable impact on patients and hospitals after initiation of ASP; reduction in healthcare-associated infection, inappropriate antibiotic prescribing, length of stay or mortality metrics and antimicrobial resistance makes ASP worthwhile as part of quality and patient safety initiatives. These benefits are well documented by other studies (Trivedi and Rosenberg, 2013 ). Since we did not evaluate specific metrics such as antibiotic consumption in days of therapy or defined daily dosing per 1000 patient days or the rate of healthcare-associated infections, the mentioned benefits may reflect participants' observations that need confirmation. IDSA and Australian Commission on Safety and Quality in Healthcare recommend both process (did the intervention result in the desired change in antimicrobial use?) and outcome measures (did the process implemented reduce or prevent resistance or other unintended consequences of antimicrobial use?) in determining the impact of antimicrobial stewardship on antimicrobial use and resistance patterns.
Lack of program funding and staffing were underscored as the most important barriers to effective ASPs. Other barriers were lack of awareness by hospital leaders of ASP and opposition by prescribers. Hospitals that have no ASP in place may use alternate ways such as telemedicine, remote consulting or identification of less specialised healthcare monitoring activities that a nurse or a non-pharmacist would be able to perform (Trivedi and Rosenberg, 2013) .
Another approach to spreading ASP across hospitals is to mandate it through national or regional legislation as well as accreditation boards, as has other regional health authorities (Australian Commission on Safety and Quality in Heath Care, 2011; Society for Healthcare Epidemiology of America et al., 2012; Trivedi et al., 2014) . Presence of electronic health records in the majority of participating institutions in GCC states, computerised decision support and use of electronic tools could assist with stewardship efforts particularly in less resourced hospitals (Forrest et al., 2014; Kullar et al., 2013) .
The survey results should be viewed with some caution due to some limitations: the nature of survey design being subject self-selective and self-reporting, with small sample size and lack of adequate representation of all GCC countries, which make the results overestimated. Moreover, there are gaps in assessing outcome of existing ASP programs, as 30-40% of participants did not know the impact of their programs on antibiotic consumption, resistance, healthcare-associated infections or direct cost.
Conclusion
The majority of these survey participants from GCC states have implemented ASP and reported subjective positive impacts in the reduction of broad-spectrum antibiotic use, hospital-acquired infection, inappropriate prescribing and antimicrobial resistance. Although these findings need further verification, it may reflect a promising opportunity to enhance existing antimicrobial stewardship programs through sharing of best practices across GCC, overcoming barriers and support the need to make ASP regulatory requirement in all healthcare facilities. 
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